A large retrospective study, the first of its kind, reported reduced rates of EO-CRC in patients younger than 50 years of age ...

Analysis of real-world data compared patients on GIMOTI (n=51) to Oral Metoclopramide (n=41), both taking GLP-1s, showing ...

Smoothie King says it is the first quick service restaurant brand with a GLP-1 focused menu.

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Taking a GLP-1 receptor agonist was associated with a lower risk for cirrhosis and related complications in patients with ...

Among patients who took at least two doses of medication, GLP-1 receptor agonists were associated with a significantly lower ...

One in eight American adults, about 12%, has taken Ozempic or a similar drug for diabetes or weight loss, recent research ...

It's no secret that doctors are helping many people lose weight by prescribing GLP-1 medications like Ozempic, Wegovy, ...

Most patients should not stop taking GLP-1 receptor agonists prior to elective surgery, according to updated guidance from several medical societies, including the American Society of ...

Rapid weight loss can cause a greater loss of muscle mass than losing weight slowly. The popularity of newer weight-loss ...

Dr. John Sosa, a double board-certified expert in family and lifestyle medicine and the Chief Medical Officer for Drip Health ...